[ Price : $8.95]
CBERs Nicole Verdun tells a Friends of Cancer Research meeting on next-generation therapies that FDA has evolved in the last decad...[ Price : $8.95]
FDA commissioner Marty Makary says the agency is planning to release in the coming days a vaccine development framework to help wi...[ Price : $8.95]
FDA warns Malaysias BioAsia Worldwide about CGMP violations in its production of finished drugs, some of which may be regulated as...[ Price : $8.95]
Cytokinetics reports topline results from its Phase 3 MAPLE-HCM clinical trial showing that aficamten significantly improved exerc...[ Price : $8.95]
FDA accepts for priority review a Regenxbio BLA seeking accelerated approval for gene therapy RGX-121 (clemidsogene lanparvovec) f...[ Price : $8.95]
FDA warns Chinas Shantou S.E.Z. Baojie Industry about CGMP violations in its production of finished drugs, some of which may be re...[ Price : $8.95]
Biotech executives, investors, and consultants say some companies are moving early clinical trials overseas due to fears of instab...[ Price : $8.95]
FDA approves a Merck NDA for Welireg (belzutifan), an oral drug for treating adults and pediatric patients aged 12 and older with ...